The biotechnology firm Allogene Therapeutics is approaching a critical juncture that will test the long-term viability of its business model....

Biotechnology firm Xilio Development is set to present new preclinical findings for its drug candidate XTX601 at the upcoming American...

PEDEVCO Corp. has concluded its 2025 fiscal year with a period of significant expansion, driven largely by its merger with...

Advanced Micro Devices is methodically expanding its footprint in the artificial intelligence sector through a dual-pronged strategy. Rather than focusing...

The scale of the current artificial intelligence infrastructure boom was thrown into sharp relief at Nvidia's recent GTC 2026 conference...

After sitting dormant for more than three decades, the Sangdong tungsten mine in South Korea is once again operational. Canadian-based...

In a decisive move underscoring its commitment to long-term strategic stability, the supervisory board of Austrian steelmaker Voestalpine has announced...

While the broader semiconductor sector navigates market fluctuations, Dutch equipment giant ASML is making tangible progress on the next frontier...

The AI infrastructure provider Nebius is positioning itself for a period of unprecedented scale. To meet surging demand from technology...

French vaccine specialist Valneva has unveiled its full-year 2025 results, presenting a nuanced financial picture that underscores a significant improvement...